Cannara Biotech Inc.
LOVE.V
TSX
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 19.39M | 18.49M | 18.14M | 16.86M | 14.29M |
| Total Other Revenue | -- | -- | -- | -40.50K | 51.20K |
| Total Revenue | 19.39M | 18.49M | 18.14M | 16.82M | 14.29M |
| Cost of Revenue | 10.28M | 10.22M | 10.82M | 9.19M | 9.24M |
| Gross Profit | 9.12M | 8.27M | 7.32M | 7.63M | 5.06M |
| SG&A Expenses | 4.07M | 3.93M | 3.99M | 3.70M | 3.56M |
| Depreciation & Amortization | 158.70K | 196.80K | 204.10K | 365.60K | 175.50K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.63M | 14.47M | 15.15M | 13.43M | 13.23M |
| Operating Income | 4.76M | 4.02M | 2.99M | 3.39M | 1.06M |
| Income Before Tax | 4.12M | 3.30M | 2.21M | 2.77M | 1.48M |
| Income Tax Expenses | 1.17M | 988.60K | 529.20K | -1.43M | -- |
| Earnings from Continuing Operations | 2.95M | 2.32M | 1.68M | 4.20M | 1.48M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.95M | 2.32M | 1.68M | 4.20M | 1.48M |
| EBIT | 4.76M | 4.02M | 2.99M | 3.39M | 1.06M |
| EBITDA | 5.61M | 5.11M | 4.07M | 4.63M | 2.12M |
| EPS Basic | 0.03 | 0.03 | 0.02 | 0.05 | 0.02 |
| Normalized Basic EPS | 0.03 | 0.02 | 0.02 | 0.02 | 0.00 |
| EPS Diluted | 0.03 | 0.03 | 0.02 | 0.04 | 0.01 |
| Normalized Diluted EPS | 0.03 | 0.02 | 0.02 | 0.02 | 0.00 |
| Average Basic Shares Outstanding | 91.43M | 90.56M | 90.02M | 90.02M | 90.02M |
| Average Diluted Shares Outstanding | 92.61M | 92.25M | 91.58M | 91.52M | 91.52M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |